carbamates has been researched along with Breast Cancer in 46 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " This study aimed to investigate the effects of a potent antioxidant (astaxanthin) co-treatment with a promising anti-cancer drug (carbendazim), which is in phase I clinical trials, on MCF-7 breast cancer cell proliferation." | 7.91 | Effects of carbendazim and astaxanthin co-treatment on the proliferation of MCF-7 breast cancer cells. ( Atalay, PB; Kuku, G; Tuna, BG, 2019) |
| "Amprenavir could suppress this phosphorylation in MCF-7 cells, which may further facilitate the association of BimEL with several pro-survival molecules." | 5.46 | Repositioning of amprenavir as a novel extracellular signal-regulated kinase-2 inhibitor and apoptosis inducer in MCF-7 human breast cancer. ( Bao, J; Chen, J; Huang, G; Jiang, W; Li, C; Li, T; Li, X; Qi, P; Shi, W; Wang, H; Wang, Y, 2017) |
| " This study aimed to investigate the effects of a potent antioxidant (astaxanthin) co-treatment with a promising anti-cancer drug (carbendazim), which is in phase I clinical trials, on MCF-7 breast cancer cell proliferation." | 3.91 | Effects of carbendazim and astaxanthin co-treatment on the proliferation of MCF-7 breast cancer cells. ( Atalay, PB; Kuku, G; Tuna, BG, 2019) |
| "Data are sparse on treatment of chronic hepatitis C virus (HCV) in cancer patients." | 1.51 | Sofosbuvir-Based Therapy in Hepatitis C Virus-Infected Cancer Patients: A Prospective Observational Study. ( Angelidakis, G; Blechacz, B; Economides, MP; Granwehr, BP; Hosry, J; Jiang, Y; Kaseb, A; Kyvernitakis, A; Mahale, P; Miller, E; Naing, A; Raad, II; Samaniego, F; Torres, HA, 2019) |
| "The growing incidence rate of breast cancer, coupled with cellular chemotherapeutic resistance, has made this disease one of the most prevalent cancers among women worldwide." | 1.46 | An Integrative Drug Repurposing Pipeline: Switching Viral Drugs to Breast Cancer. ( Basavanna, LN; Karuppasamy, R; Sequeira, VM; Veerappapillai, S; Verma, K, 2017) |
| "Amprenavir could suppress this phosphorylation in MCF-7 cells, which may further facilitate the association of BimEL with several pro-survival molecules." | 1.46 | Repositioning of amprenavir as a novel extracellular signal-regulated kinase-2 inhibitor and apoptosis inducer in MCF-7 human breast cancer. ( Bao, J; Chen, J; Huang, G; Jiang, W; Li, C; Li, T; Li, X; Qi, P; Shi, W; Wang, H; Wang, Y, 2017) |
| "In this study, MCF-7 breast cancer cells were treated with iejimalide A or B and analyzed for changes in cell-cycle dynamics, apoptosis, lysosomal pH, cytoplasmic pH, mitochondrial membrane potential, and generation of reactive oxygen species." | 1.36 | Iejimalides A and B inhibit lysosomal vacuolar H+-ATPase (V-ATPase) activity and induce S-phase arrest and apoptosis in MCF-7 cells. ( Davisson, VJ; Devitt, E; Helquist, P; Kluesner, N; McHenry, P; McKee, E; Schweitzer, D; Tenniswood, M; Wang, WL, 2010) |
| " Consistent with this hypothesis, two recent papers reported that gamma-secretase inhibitor I (GSI I), Z-LLNle-CHO, is toxic to breast cancer cells both in vitro and in vivo." | 1.35 | The cytotoxicity of gamma-secretase inhibitor I to breast cancer cells is mediated by proteasome inhibition, not by gamma-secretase inhibition. ( Allalunis-Turner, J; Han, J; Hendzel, MJ; Ma, I, 2009) |
| "Carbamates 4 and 5 were 2." | 1.35 | Latrunculin A and its C-17-O-carbamates inhibit prostate tumor cell invasion and HIF-1 activation in breast tumor cells. ( Awate, B; Khanfar, MA; Liu, Y; Muralidharan, A; Nagle, DG; Sayed, KA; Shah, G; Shallal, HM; Youssef, DT; Zhou, YD, 2008) |
| "Discodermolide-treated breast carcinoma cells displayed spectacular rearrangement of the microtubule cytoskeleton, including extensive microtubule bundling." | 1.29 | Discodermolide, a cytotoxic marine agent that stabilizes microtubules more potently than taxol. ( Day, BW; Gunasekera, SP; Hamel, E; Kowalski, RJ; Lin, CM; Longley, RE; Rosenkranz, HS; ter Haar, E, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (15.22) | 18.7374 |
| 1990's | 6 (13.04) | 18.2507 |
| 2000's | 13 (28.26) | 29.6817 |
| 2010's | 18 (39.13) | 24.3611 |
| 2020's | 2 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Usama, SM | 1 |
| Marker, SC | 1 |
| Caldwell, DR | 1 |
| Patel, NL | 1 |
| Feng, Y | 1 |
| Kalen, JD | 1 |
| St Croix, B | 1 |
| Schnermann, MJ | 1 |
| Limmer, A | 1 |
| Swali, R | 1 |
| Robare, S | 1 |
| Aydin, D | 1 |
| Arslan, M | 1 |
| Sanyal, A | 1 |
| Sanyal, R | 1 |
| Ke, X | 1 |
| Yang, C | 1 |
| Cheng, W | 1 |
| Yang, YY | 1 |
| Zhang, Q | 1 |
| Xu, H | 1 |
| Liu, R | 1 |
| Gao, P | 1 |
| Yang, X | 1 |
| Li, P | 1 |
| Wang, X | 1 |
| Zhang, Y | 2 |
| Bi, K | 1 |
| Li, Q | 1 |
| Torres, HA | 1 |
| Economides, MP | 1 |
| Angelidakis, G | 1 |
| Hosry, J | 1 |
| Kyvernitakis, A | 1 |
| Mahale, P | 1 |
| Jiang, Y | 1 |
| Miller, E | 1 |
| Blechacz, B | 1 |
| Naing, A | 1 |
| Samaniego, F | 1 |
| Kaseb, A | 1 |
| Raad, II | 1 |
| Granwehr, BP | 1 |
| Li, L | 1 |
| Li, J | 1 |
| Zuo, Y | 1 |
| Dang, D | 1 |
| Frost, JA | 1 |
| Yang, Q | 1 |
| Atalay, PB | 1 |
| Kuku, G | 1 |
| Tuna, BG | 1 |
| Loosley, BC | 1 |
| Andersen, RJ | 1 |
| Dake, GR | 1 |
| Lamberto, I | 1 |
| Plano, D | 1 |
| Moreno, E | 1 |
| Font, M | 1 |
| Palop, JA | 1 |
| Sanmartín, C | 1 |
| Encío, I | 1 |
| Dayalan Naidu, S | 1 |
| Samarasinghe, K | 1 |
| Van Hecke, GC | 1 |
| Pheely, A | 1 |
| Boronina, TN | 1 |
| Cole, RN | 1 |
| Benjamin, IJ | 1 |
| Cole, PA | 1 |
| Ahn, YH | 1 |
| Dinkova-Kostova, AT | 1 |
| Schmidt, A | 1 |
| Meissner, RS | 1 |
| Gentile, MA | 1 |
| Chisamore, MJ | 1 |
| Opas, EE | 1 |
| Scafonas, A | 1 |
| Cusick, TE | 1 |
| Gambone, C | 1 |
| Pennypacker, B | 1 |
| Hodor, P | 1 |
| Perkins, JJ | 1 |
| Bai, C | 1 |
| Ferraro, D | 1 |
| Bettoun, DJ | 1 |
| Wilkinson, HA | 1 |
| Alves, SE | 1 |
| Flores, O | 1 |
| Ray, WJ | 1 |
| Sun, T | 1 |
| Wang, Y | 3 |
| Xu, J | 1 |
| Zhao, X | 1 |
| Vangveravong, S | 1 |
| Mach, RH | 1 |
| Xia, Y | 1 |
| Vaden, RM | 1 |
| Gligorich, KM | 1 |
| Jana, R | 1 |
| Sigman, MS | 1 |
| Welm, BE | 1 |
| Marín-Ramos, NI | 1 |
| Alonso, D | 1 |
| Ortega-Gutiérrez, S | 1 |
| Ortega-Nogales, FJ | 1 |
| Balabasquer, M | 1 |
| Vázquez-Villa, H | 1 |
| Andradas, C | 1 |
| Blasco-Benito, S | 1 |
| Pérez-Gómez, E | 1 |
| Canales, Á | 1 |
| Jiménez-Barbero, J | 1 |
| Marquina, A | 1 |
| del Prado, JM | 1 |
| Sánchez, C | 1 |
| Martín-Fontecha, M | 1 |
| López-Rodríguez, ML | 1 |
| Karuppasamy, R | 1 |
| Verma, K | 1 |
| Sequeira, VM | 1 |
| Basavanna, LN | 1 |
| Veerappapillai, S | 1 |
| Jiang, W | 1 |
| Li, X | 1 |
| Li, T | 1 |
| Wang, H | 1 |
| Shi, W | 1 |
| Qi, P | 1 |
| Li, C | 1 |
| Chen, J | 1 |
| Bao, J | 1 |
| Huang, G | 1 |
| Gediya, LK | 1 |
| Khandelwal, A | 1 |
| Patel, J | 1 |
| Belosay, A | 1 |
| Sabnis, G | 1 |
| Mehta, J | 1 |
| Purushottamachar, P | 1 |
| Njar, VC | 1 |
| Yenjerla, M | 1 |
| Cox, C | 1 |
| Wilson, L | 1 |
| Jordan, MA | 1 |
| Han, J | 1 |
| Ma, I | 1 |
| Hendzel, MJ | 1 |
| Allalunis-Turner, J | 1 |
| Hiers, C | 1 |
| Cook, J | 1 |
| Sales, E | 1 |
| McHenry, P | 1 |
| Wang, WL | 1 |
| Devitt, E | 1 |
| Kluesner, N | 1 |
| Davisson, VJ | 1 |
| McKee, E | 1 |
| Schweitzer, D | 1 |
| Helquist, P | 1 |
| Tenniswood, M | 1 |
| Yadlapalli, RK | 1 |
| Chourasia, OP | 1 |
| Vemuri, K | 1 |
| Sritharan, M | 1 |
| Perali, RS | 1 |
| Li, H | 1 |
| Wood, JT | 1 |
| Whitten, KM | 1 |
| Vadivel, SK | 1 |
| Seng, S | 1 |
| Makriyannis, A | 1 |
| Avraham, HK | 1 |
| Bielawski, K | 1 |
| Bielawska, A | 1 |
| Wołczyński, S | 1 |
| Shin, Y | 1 |
| Choy, N | 1 |
| Turner, TR | 1 |
| Balachandran, R | 2 |
| Madiraju, C | 1 |
| Day, BW | 3 |
| Curran, DP | 1 |
| FALKSON, G | 2 |
| FALKSON, HC | 1 |
| DEJAGER, ME | 1 |
| Struck, RF | 1 |
| Waud, WR | 1 |
| Bonefeld-Jorgensen, EC | 1 |
| Grünfeld, HT | 1 |
| Gjermandsen, IM | 1 |
| Byun, JA | 1 |
| Lee, SH | 1 |
| Jung, BH | 1 |
| Choi, MH | 1 |
| Moon, MH | 1 |
| Chung, BC | 1 |
| Wiesen, KM | 1 |
| Xia, S | 1 |
| Yang, CP | 1 |
| Horwitz, SB | 1 |
| Sayed, KA | 1 |
| Khanfar, MA | 1 |
| Shallal, HM | 1 |
| Muralidharan, A | 1 |
| Awate, B | 1 |
| Youssef, DT | 1 |
| Liu, Y | 1 |
| Zhou, YD | 1 |
| Nagle, DG | 1 |
| Shah, G | 1 |
| Anderson, WK | 1 |
| McPherson, HL | 1 |
| New, JS | 1 |
| Rick, AC | 1 |
| Lundberg, B | 1 |
| ter Haar, E | 2 |
| Kowalski, RJ | 1 |
| Hamel, E | 1 |
| Lin, CM | 1 |
| Longley, RE | 1 |
| Gunasekera, SP | 1 |
| Rosenkranz, HS | 1 |
| Klotz, DM | 1 |
| Arnold, SF | 1 |
| McLachlan, JA | 1 |
| Welsh, MJ | 1 |
| Grant, SG | 1 |
| Rekha, GK | 1 |
| Devaraj, VR | 1 |
| Sreerama, L | 1 |
| Lee, MJ | 1 |
| Nagasawa, HT | 1 |
| Sladek, NE | 1 |
| Hammond, LA | 1 |
| Davidson, K | 1 |
| Lawrence, R | 1 |
| Camden, JB | 1 |
| Von Hoff, DD | 1 |
| Weitman, S | 1 |
| Izbicka, E | 1 |
| Dolapsakis, G | 1 |
| Vlachonikolis, IG | 1 |
| Varveris, C | 1 |
| Tsatsakis, AM | 1 |
| Elias, EG | 1 |
| Band, PR | 1 |
| Mittelman, A | 1 |
| Colsky, J | 1 |
| Regelson, W | 1 |
| Shnider, BI | 1 |
| Hanley, JA | 1 |
| Karev, NI | 1 |
| Garin, AM | 1 |
| Blokhina, NG | 1 |
| Pershin, MP | 1 |
| Trapeznikova, MF | 1 |
| Aboul-Enein, HY | 1 |
| Islam, MR | 1 |
| Mirvish, SS | 1 |
| Moore, GE | 1 |
| Bross, ID | 1 |
| Ausman, R | 1 |
| Nadler, S | 1 |
| Jones, R | 1 |
| Slack, N | 1 |
| Rimm, AA | 1 |
1 review available for carbamates and Breast Cancer
| Article | Year |
|---|---|
The carcinogenic action and metabolism of urethan and N-hydroxyurethan.
Topics: Adenoma; Animals; Animals, Newborn; Body Fluids; Breast Neoplasms; Carbamates; Carcinogens; Carcinom | 1968 |
2 trials available for carbamates and Breast Cancer
| Article | Year |
|---|---|
Clinical evaluation of two weekly dose schedules of 'IC-140'. 4-N, N-bis (2-Chloroethyl) amino phenyl N (P-carboxyphenyl) carbamate, in the treatmentment of solid tumors 1,2.
Topics: Adenocarcinoma; Breast Neoplasms; Carbamates; Clinical Trials as Topic; Drug Administration Schedule | 1975 |
Effects of meturedepa (NSC-51325) in 233 patients with advanced cancer. Eastern Clinical Drug Evaluation Program.
Topics: Alkylating Agents; Azirines; Breast Neoplasms; Carbamates; Clinical Trials as Topic; Female; Humans; | 1968 |
43 other studies available for carbamates and Breast Cancer
| Article | Year |
|---|---|
Targeted Fluorogenic Cyanine Carbamates Enable
Topics: Animals; Breast Neoplasms; Carbamates; Female; Fluorescent Dyes; Humans; Immunoconjugates; Mice; Mic | 2021 |
Multiple Pigmented Lesions of the Breast Following Ipsilateral Breast Carcinoma.
Topics: Aged; Androstadienes; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzimi | 2020 |
Hooked on Cryogels: A Carbamate Linker Based Depot for Slow Drug Release.
Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Carbamates; Cell Proliferation; Cryogels; Doxorubicin | 2017 |
Delivery of NF-κB shRNA using carbamate-mannose modified PEI for eliminating cancer stem cells.
Topics: Antibiotics, Antineoplastic; Apoptosis; Breast Neoplasms; Carbamates; Cell Movement; Cell Proliferat | 2018 |
Highly Sensitive Quantification Method for Amine Submetabolome Based on AQC-Labeled-LC-Tandem-MS and Multiple Statistical Data Mining: A Potential Cancer Screening Approach.
Topics: Amines; Aminoquinolines; Biomarkers, Tumor; Breast Neoplasms; Carbamates; Chromatography, High Press | 2018 |
Sofosbuvir-Based Therapy in Hepatitis C Virus-Infected Cancer Patients: A Prospective Observational Study.
Topics: Aged; Antiviral Agents; Benzimidazoles; Breast Neoplasms; Carbamates; Carcinoma, Hepatocellular; Dru | 2019 |
Activation of KCNQ Channels Prevents Paclitaxel-Induced Peripheral Neuropathy and Associated Neuropathic Pain.
Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carbamates; Cell Line, Tumor; Drug Rep | 2019 |
Effects of carbendazim and astaxanthin co-treatment on the proliferation of MCF-7 breast cancer cells.
Topics: Benzimidazoles; Breast Neoplasms; Carbamates; Cell Cycle Checkpoints; Cell Proliferation; Cell Survi | 2019 |
Total synthesis of cladoniamide G.
Topics: Antineoplastic Agents; Breast Neoplasms; Carbamates; Drug Screening Assays, Antitumor; Humans; Indol | 2013 |
Bisacylimidoselenocarbamates cause G2/M arrest associated with the modulation of CDK1 and Chk2 in human breast cancer MCF-7 cells.
Topics: Antineoplastic Agents; Apoptosis; Breast; Breast Neoplasms; Carbamates; Caspases; CDC2 Protein Kinas | 2013 |
Sulphoxythiocarbamates modify cysteine residues in HSP90 causing degradation of client proteins and inhibition of cancer cell proliferation.
Topics: Adenosine Triphosphate; Amino Acid Sequence; Animals; Breast Neoplasms; Carbamates; Cell Growth Proc | 2014 |
Identification of an anabolic selective androgen receptor modulator that actively induces death of androgen-independent prostate cancer cells.
Topics: Anabolic Agents; Androgen Receptor Antagonists; Androgens; Animals; Apoptosis; Azasteroids; Blotting | 2014 |
Using SV119-gold nanocage conjugates to eradicate cancer stem cells through a combination of photothermal and chemo therapies.
Topics: Antineoplastic Agents; Azabicyclo Compounds; Breast Neoplasms; Carbamates; Cell Line, Tumor; Cell Su | 2014 |
The small molecule C-6 is selectively cytotoxic against breast cancer cells and its biological action is characterized by mitochondrial defects and endoplasmic reticulum stress.
Topics: Adenocarcinoma; Antineoplastic Agents; Benzhydryl Compounds; Breast Neoplasms; Carbamates; Cell Line | 2014 |
New inhibitors of angiogenesis with antitumor activity in vivo.
Topics: Angiogenesis Inhibitors; Animals; Benzamides; Breast Neoplasms; Carbamates; Cell Hypoxia; Cell Line, | 2015 |
An Integrative Drug Repurposing Pipeline: Switching Viral Drugs to Breast Cancer.
Topics: Anilides; Antineoplastic Agents; Antiviral Agents; Breast Neoplasms; Carbamates; Computational Biolo | 2017 |
Repositioning of amprenavir as a novel extracellular signal-regulated kinase-2 inhibitor and apoptosis inducer in MCF-7 human breast cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bcl-2-Like Protein 11; Breast Neoplasms; Carbamates; Cell | 2017 |
Design, synthesis, and evaluation of novel mutual prodrugs (hybrid drugs) of all-trans-retinoic acid and histone deacetylase inhibitors with enhanced anticancer activities in breast and prostate cancer cells in vitro.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carbamates; Cell Line, Tumor; Cell Proliferation; | 2008 |
Carbendazim inhibits cancer cell proliferation by suppressing microtubule dynamics.
Topics: Benzimidazoles; Breast Neoplasms; Carbamates; Cell Line, Tumor; Cell Proliferation; Colchicine; Dose | 2009 |
The cytotoxicity of gamma-secretase inhibitor I to breast cancer cells is mediated by proteasome inhibition, not by gamma-secretase inhibition.
Topics: Adenocarcinoma; Amyloid Precursor Protein Secretases; Breast Neoplasms; Carbamates; Cell Line, Tumor | 2009 |
Case report of a 30.8 pound cystosarcoma phyllodes of breast.
Topics: Biopsy; Breast Neoplasms; Carbamates; Female; Humans; Mastectomy, Modified Radical; Middle Aged; Phy | 2009 |
Iejimalides A and B inhibit lysosomal vacuolar H+-ATPase (V-ATPase) activity and induce S-phase arrest and apoptosis in MCF-7 cells.
Topics: Apoptosis; Breast Neoplasms; Carbamates; Cell Line, Tumor; Epithelial Cells; Female; Humans; Hydroge | 2010 |
Synthesis and in vitro anticancer and antitubercular activity of diarylpyrazole ligated dihydropyrimidines possessing lipophilic carbamoyl group.
Topics: Antineoplastic Agents; Antitubercular Agents; Breast Neoplasms; Carbamates; Cell Line, Tumor; Cell P | 2012 |
Inhibition of fatty acid amide hydrolase activates Nrf2 signalling and induces heme oxygenase 1 transcription in breast cancer cells.
Topics: Active Transport, Cell Nucleus; Amidohydrolases; Antineoplastic Agents; Arachidonic Acids; Benzamide | 2013 |
Synthesis, DNA-binding activity and cytotoxicity of carbamate derivatives of Hoechst 33258 in breast cancer MCF-7 cells.
Topics: Animals; Antineoplastic Agents; Binding Sites; Bisbenzimidazole; Breast Neoplasms; Carbamates; Cattl | 2002 |
Discodermolide/Dictyostatin hybrids: synthesis and biological evaluation.
Topics: Alkanes; Antineoplastic Agents; Breast Neoplasms; Carbamates; Female; Humans; Lactones; Macrolides; | 2002 |
CLINICAL EVALUATION OF BIS(2-CHLOROPROPYL)CARBAMIC ACID, ETHYL ESTER (6W54, NSC-53105).
Topics: Agranulocytosis; Antineoplastic Agents; Biomedical Research; Bone Marrow Diseases; Breast Neoplasms; | 1964 |
CATALASE ACTIVITY IN THE EPIDERMIS OF PATIENTS WITH ADVANCED CANCER.
Topics: Antineoplastic Agents; Breast Neoplasms; Carbamates; Catalase; Clinical Enzyme Tests; Cobalt Isotope | 1964 |
Thiolo-, thiono- and dithiocarbonate and thiocarbamate derivatives of demethylpenclomedine as novel anticancer agents.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carbamates; Carbonates; Female; Humans; Mice; Mice | 2006 |
Effect of pesticides on estrogen receptor transactivation in vitro: a comparison of stable transfected MVLN and transient transfected MCF-7 cells.
Topics: Biological Assay; Breast Neoplasms; Carbamates; Cell Line, Tumor; Dose-Response Relationship, Drug; | 2005 |
Analysis of polyamines as carbamoyl derivatives in urine and serum by liquid chromatography-tandem mass spectrometry.
Topics: Biomarkers, Tumor; Breast Neoplasms; Calibration; Carbamates; Chemical Fractionation; Chromatography | 2008 |
Wild-type class I beta-tubulin sensitizes Taxol-resistant breast adenocarcinoma cells harboring a beta-tubulin mutation.
Topics: Adenocarcinoma; Alkanes; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carbamates; Cell Line, | 2007 |
Latrunculin A and its C-17-O-carbamates inhibit prostate tumor cell invasion and HIF-1 activation in breast tumor cells.
Topics: Animals; Breast Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Carbamates; Drug Screening Assay | 2008 |
Synthesis and murine antineoplastic activity of bis[(carbamoyloxy)methyl] derivatives of pyrrolo[2,1-a]isoquinoline.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carbamates; Chemical Phenomena; Chemistry; Isoquin | 1984 |
Cytotoxic activity of two new lipophilic steroid nitrogen carbamates incorporated into low-density lipoprotein.
Topics: Antineoplastic Agents; Breast Neoplasms; Carbamates; Chemical Phenomena; Chemistry, Pharmaceutical; | 1994 |
Discodermolide, a cytotoxic marine agent that stabilizes microtubules more potently than taxol.
Topics: Alkanes; Animals; Antineoplastic Agents; Breast Neoplasms; Burkitt Lymphoma; Calcium; Carbamates; Ce | 1996 |
Inhibition of 17 beta-estradiol and progesterone activity in human breast and endometrial cancer cells by carbamate insecticides.
Topics: Binding, Competitive; Breast Neoplasms; Carbamates; Endometrial Neoplasms; Estradiol; Estrogen Antag | 1997 |
The potent microtubule-stabilizing agent (+)-discodermolide induces apoptosis in human breast carcinoma cells--preliminary comparisons to paclitaxel.
Topics: Alkanes; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carbamates; Diploidy; DNA Fragmentation | 1998 |
Inhibition of human class 3 aldehyde dehydrogenase, and sensitization of tumor cells that express significant amounts of this enzyme to oxazaphosphorines, by chlorpropamide analogues.
Topics: Aldehyde Dehydrogenase; Antineoplastic Agents; Breast Neoplasms; Carbamates; Chlorpropamide; Cycloph | 1998 |
Exploring the mechanisms of action of FB642 at the cellular level.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzimidazoles; Breast Neoplasms; Carbamates; Cell Cycle; | 2001 |
Mammographic findings and occupational exposure to pesticides currently in use on Crete.
Topics: Adult; Aged; Agricultural Workers' Diseases; Breast Neoplasms; Carbamates; Female; Follow-Up Studies | 2001 |
[Results of the clinical study of a preparation of diiodobenzotef in malignant tumors].
Topics: Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzamides; Breast Neoplasms; Carbamates; | 1975 |
Direct enantiomeric high performance liquid chromatographic separation of aminoglutethimide and its major metabolite on a series of Chiralcel OD and Chiralcel OJ columns and its application to biological fluids.
Topics: Aminoglutethimide; Body Fluids; Breast Neoplasms; Carbamates; Cellulose; Chromatography, High Pressu | 1991 |